Given that, it's hardly encouraging that Biodexa has taken a big step forward ahead of Recursion in the development of its ...

Recursion Pharmaceuticals and Relay Therapeutics both leverage their respective AI drug discovery platforms to potentially develop novel therapeutic candidates.